Cargando…

Correction: Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease

Detalles Bibliográficos
Autores principales:	Zhu, Lijun, Fang, Yangliang, Gao, Beibei, Jin, Xiangbo, Zheng, Jiamin, He, Ying, Huang, Jinyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804942/ https://www.ncbi.nlm.nih.gov/pubmed/36585611 http://dx.doi.org/10.1186/s12872-022-03027-4

Ejemplares similares

Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
por: Zhu, Lijun, et al.
Publicado: (2022)

Impact of epicardial adipose tissue volume on hemodynamically significant coronary artery disease in Chinese patients with known or suspected coronary artery disease
por: Jin, Xiangbo, et al.
Publicado: (2023)

The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels
por: Zhu, Lijun, et al.
Publicado: (2022)

Statins and Lp(a) – the plot thickens
por: Enkhmaa, Byambaa, et al.
Publicado: (2019)

Correction: Effect of statin on life prognosis in Japanese patients undergoing hemodialysis
por: Ota, Yuki, et al.
Publicado: (2020)

Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
por: Pechlivanis, Sonali, et al.
Publicado: (2020)

Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
por: Mysore, Yashavanthi, et al.
Publicado: (2021)

Correction: Acute renal artery infarction secondary to dysfibrinogenemia
Publicado: (2018)

Correction: Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
Publicado: (2018)

Correction to: Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
por: Singh, Pratibha, et al.
Publicado: (2021)

Correction to: Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention
por: Volpe, Massimo, et al.
Publicado: (2022)

Correction: primary, secondary, and tertiary prevention of cervical cancer
por: Kim, Hee Seung
Publicado: (2014)

Correction to: Consensus on the secondary prevention of primary liver cancer
por: Nan, Yuemin, et al.
Publicado: (2022)

Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus
por: Kostner, Karam M., et al.
Publicado: (2022)

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India
por: Sharma, Krishna K, et al.
Publicado: (2009)

Underutilization of Statin Therapy for Secondary Prevention of Cardiovascular Disease Among Older Adults
por: Musich, Shirley, et al.
Publicado: (2019)

Correction to: Cardiovascular Event Rates in Statin‑Treated Korean Patients with Cardiovascular Disease: Estimates from a Real‑World Population Using Electronic Medical Record Data
por: Kwon, Osung, et al.
Publicado: (2021)

Correction: How Statins May Protect against Alzheimer Disease
Publicado: (2012)

Correction: RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2013)

Correction: Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review
por: Jahangiri, Reza, et al.
Publicado: (2023)

Correction to: Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study
por: Del Pinto, Rita, et al.
Publicado: (2023)

Correction: Impact of Fetuin-A, Lp(a), matrix gla protein and macrophage density on calcific aortic valve disease: a clinical study
por: Liu, Cong, et al.
Publicado: (2023)

Correction to: Axillary artery and brachial plexus injury secondary to blunt trauma
Publicado: (2022)

Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents
por: Liu, Huixing, et al.
Publicado: (2022)

Elevated Lp(a) Levels Correlate with Severe and Multiple Coronary Artery Stenotic Lesions
por: Al Hageh, Cynthia, et al.
Publicado: (2023)

Role of Statins in Coronary Artery Disease
por: Lim, Sang Yup
Publicado: (2013)

Correction to: Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease
Publicado: (2023)

Correction: Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome
por: Szymula, Agnieszka, et al.
Publicado: (2019)

Correction: Small-Size Circulating Endothelial Microparticles in Coronary Artery Disease
Publicado: (2014)

Correction: Plasma Haptoglobin Concentrations Are Elevated in Patients with Coronary Artery Disease
por: Lee, Ching-Wei, et al.
Publicado: (2014)

Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
por: Enkhmaa, Byambaa, et al.
Publicado: (2020)

Correction: Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes
Publicado: (2018)

Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
por: Zhu, Ling, et al.
Publicado: (2020)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Correction: A Case of Suspected Statin-Related Delayed Onset Necrotizing Myositis
por: Smirlis, Elias, et al.
Publicado: (2022)

Correction: Urinary Bisphenol A Concentration and Angiography-Defined Coronary Artery Stenosis
por: Melzer, David, et al.
Publicado: (2012)

Correction to: VEGF‐C and Mortality in Patients With Suspected or Known Coronary Artery Disease
Publicado: (2020)

Correction: Nomogram predicts atrial fibrillation after coronary artery by pass grafting
por: Gong, Jingshuai, et al.
Publicado: (2022)

High‐Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease
Publicado: (2019)

Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m96kvkikrkg9stn2bbhoprbu36